Back to Search
Start Over
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology
- Source :
- Breast Cancer Research : BCR, Breast Cancer Research, Vol 22, Iss 1, Pp 1-14 (2020)
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- BackgroundBreast cancer is the most common malignancy to spread to the orbit and periorbit, and the invasive lobular carcinoma (ILC) histologic subtype of breast cancer has been reported to form these ophthalmic metastases (OM) more frequently than invasive ductal carcinomas (IDC). We herein report our single academic institution experience with breast cancer OM with respect to anatomical presentation, histology (lobular vs. ductal), treatment, and survival.MethodsWe employed the natural language processing platform, TIES (Text Information Extraction System), to search 2.3 million de-identified patient pathology and radiology records at our institution in order to identify patients with OM secondary to breast cancer. We then compared the resultant cohort, the “OM cohort,” to two other representative metastatic breast cancer patient (MBC) databases from our institution. Histological analysis of selected patients was performed.ResultsOur TIES search and manual refinement ultimately identified 28 patients who were diagnosed with breast cancer between 1995 and 2016 that subsequently developed OM. Median age at diagnosis was 54 (range 28–77) years of age. ER, PR, and HER2 status from the 28 patients with OM did not differ from other patients with MBC from our institution. The relative proportion of patients with ILC was significantly higher in the OM cohort (32.1%) than in other MBC patients in our institution (11.3%,p = 0.007). Median time to first OM in the OM cohort was 46.7 months, and OM were the second most frequent first metastases after bony metastases. After diagnosis of the first distant metastasis of any kind, median survival of patients with ILC (21.4 months) was significantly shorter than that of patients with IDC (55.3 months,p = 0.03). Nine patients developed bilateral OM. We observed a significant co-occurrence of OM and central nervous system metastases (p = 0.0053). The histological analysis revealed an interesting case in which the primary tumor was of a mixed ILC/IDC subtype, while only ILC was present in the OM.ConclusionsOM from breast cancer are illustrative of the difference in metastatic behavior of ILC versus IDC and should be considered when treating patients with ILC, especially in those with complaints of visual acuity changes.
- Subjects :
- Adult
medicine.medical_specialty
Receptor, ErbB-2
Breast Neoplasms
Eye
Malignancy
lcsh:RC254-282
Metastasis
03 medical and health sciences
Breast cancer
0302 clinical medicine
Surgical oncology
Humans
Medicine
skin and connective tissue diseases
Aged
Retrospective Studies
business.industry
Carcinoma, Ductal, Breast
Middle Aged
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Prognosis
Invasive lobular carcinoma
medicine.disease
Primary tumor
Metastatic breast cancer
body regions
Survival Rate
Carcinoma, Lobular
Ophthalmology
Treatment Outcome
Receptors, Estrogen
Lymphatic Metastasis
030220 oncology & carcinogenesis
Cohort
030221 ophthalmology & optometry
Orbital Neoplasms
Female
Radiotherapy, Intensity-Modulated
Radiology
Receptors, Progesterone
business
Follow-Up Studies
Research Article
Subjects
Details
- ISSN :
- 1465542X
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Breast Cancer Research
- Accession number :
- edsair.doi.dedup.....1cf6f5ab8adbc1ce476f93c3629b5e2f
- Full Text :
- https://doi.org/10.1186/s13058-020-01309-3